ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Rare Pediatric Disease Designations for WP1066 americanpharmaceuticalreview
December 18, 2020Moleculin Biotech announced the US Food and Drug Administration (FDA) has approved its request for a "Rare Pediatric Disease" designation for its drug candidate WP1066. -
Moleculin Provides Update on Coronavirus Drug Development americanpharmaceuticalreview
June 03, 2020Moleculin Biotech announced the US Food and Drug Administration (FDA) has granted the Company's request for a Pre-IND Meeting to provide guidance regarding the Company's plan to study its drug candidate, WP1122 ...
Pharma Sources Insight January 2025
